Medtasker is made and published by Nimblic. AppBrain is an independent app data site and isn't affiliated with Nimblic. The app name, icon, screenshots and description belong to Nimblic and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- October 12, 2026
Rankings
App Store top chartsApp Store Rankings for Medtasker
Competitors
Similar apps and more from NimblicAlternatives to Medtasker
Also available on Google Play
Releases
Updates seen on the App Store- Version
- 2.7.0
- Launched
- April 2024
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Medtasker for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 78.1 MB
- Content rating
- High
Technologies used by Medtasker
About the app and developer
About Medtasker
Medtasker is a medical app developed by Nimblic.
User Ratings
The app has no ratings yet.
App Information
Medtasker is freely available from the App Store. The app size is 78.10 MB. The latest version available is 2.7.0. The last update was on October 12, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since April 2024.
Developer information for Nimblic
Address:
Store listing
By Nimblic, from the App Store
Description by Nimblic Written by the developer, not by AppBrain. Click to read.
The platform coordinates work in real time, ensuring tasks and messages are delivered to the right person every time with clear accountability and visibility. Medtasker supports everything from routine requests to critical events such as MET calls and Code responses.
With Medtasker, you can:
・Improve patient safety through faster, clearer communication.
・Reduce staff stress by minimising interruptions and saving time.
・Increase operational efficiency with automated workflows and real-time task visibility.
・Enable teams to self-manage and collaborate on tasks.
Medtasker. Better hospital communication.